The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals.

Lisa Townshend-BulsonElena RoikYoussef BarbourDana J T BrudenChriss E HomanHannah G F EsperaTimothy J StevensonAnnette M HewittWileina RhodesJames E GoveJulia N PlotnikMary M SnowballJohn McGilvrayBrenna C SimonsJanet M JohnstonBrian J McMahon

Published in: PloS one (2021)

In the real-world setting, sofosbuvir-based treatment is safe, effective, and well tolerated in AN/AI patients. Sustained virologic response was high regardless of HCV genotype or cirrhosis status.

Keyphrases

hepatitis c virus
end stage renal disease
chronic kidney disease
newly diagnosed
human immunodeficiency virus
artificial intelligence
machine learning
hiv infected
hepatitis c virus infection
deep learning
replacement therapy